Ireland
--:--IST
Active, not recruiting Observational

Automatic PredICtion of Edema After Stroke

NCT04057690 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-04-01
Last updated
2025-09-10

Condition(s) studied

Stroke, AcuteBrain Edema

Study summary

To use machine learning for early detection of malignant brain edema in patients with MCA ischemia

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Acute ≥ subtotal MCA infarct (M1-M2 occlusion) * with or without malignant brain swelling * with or without reperfusion therapy * with or without neurosurgical decompression * with or without death following malignant brain edema Exclusion Criteria: * Non-acute MCA infarct * \< subtotal MCA infarct

Primary outcome measure(s)

  • Number of patients with stroke-related malignant edema after recanalization treatment detected by deep learning algorithms — 4/2019-3/2022
    Deep learning algorithms will be used for automatic identification of specific image findings and specific clinical data that indicate a stroke-related malignant edema. Primary outcome measures are Sensitivity/Specificity/negative predictive value/positive predictive value of early detection of patients developing stroke-related malignant edema based on initial CT and 24 hour follow up CT and clinical parameters.

Trial sites (19)

FacilityCityRegionStatus
St. John's Hospital Vienna Austria
Charité Universitätsmedizin Berlin Berlin Germany
Universitätsklinikum Bonn Bonn Germany
Fraunhofer- Gesellschaft zur Förderung der angewandten Forschung e.V., Fraunhofer MEVIS Bremen Germany
Universitätsklinikum Düsseldorf Düsseldorf Germany
Universitätsklinikum Hamburg-Eppendorf Hamburg Germany
Klinikum der Medizinischen Hochschule Hannover Hanover Germany
Universitätsklinikum Heidelberg Heidelberg Germany
Universitätsklinikum Leipzig Leipzig Germany
Klinikum der Ludwig-Maximilians-Universität München Munich Germany
Technische Universität München Munich Germany
Universitätsklinikum Münster Münster Germany
Universitätsklinikum Regensburg Regensburg Germany
Klinikum Stuttgart Stuttgart Germany
University Hospital Tuebingen Tübingen Germany
Hertie Institute for AI in Brain Health Tübingen Germany
Universitätsklinikum Ulm Ulm Germany
Universitätsklinikum Würzburg Würzburg Germany
BRAINOMIX Limited Oxford United Kingdom
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04057690 on ClinicalTrials.gov ↗ ← All trials in Germany